Scinai Immunotherapeutics (SCNI) Share-based Compensation (2018 - 2026)

Scinai Immunotherapeutics (SCNI) posted Share-based Compensation of $70000.0 for Q1 2026, down 77.78% sequentially from $315000.0 in Q4 2025.

Scinai Immunotherapeutics (SCNI) Share-based Compensation (2018 - 2026) Analysis & Trends

Scinai Immunotherapeutics has reported Share-based Compensation for 9 years, with the latest figure at $70000.0 in Q1 2026.

Quarterly Share-based Compensation changed N/A year-over-year to $70000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $880000.0 (changed N/A YoY) and the FY2025 annual result came in at $315000.0, down 66.91% from the prior year.
Share-based Compensation declined to $70000.0 in Q1 2026 per SCNI's latest filing, from $315000.0 in the prior quarter.
Over five years, Share-based Compensation peaked at $650000.0 in Q2 2024 and troughed at $70000.0 in Q1 2026.
A 5-year average of $329571.4 and a median of $324500.0 in 2022 frame the typical range for Share-based Compensation.
The sharpest annual moves came in 2022 and 2024: Share-based Compensation slumped 86.78% in 2022, then surged 214.01% in 2024.
Over 5 years, Share-based Compensation stood at $398000.0 in 2022, then rose by 13.82% to $453000.0 in 2023, then gained by 4.64% to $474000.0 in 2024, then tumbled by 33.54% to $315000.0 in 2025, then tumbled by 77.78% to $70000.0 in 2026.
According to Business Quant data, Share-based Compensation over the past three periods registered $70000.0, $315000.0, and $474000.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Stock Comp. (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	108.10 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	243.00 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	120.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	137.41 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	86.63 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	41.25 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	28.05 Mn
10	Scinai Immunotherapeutics	1.08 Mn	-3.11 Bn	-1.12 Mn	70,000.00

Download Data